Home > Insider Trading > Filing (0001181431-14-003072)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1487371	Genmark Diagnostics Inc.	GNMK	Surgical & Medical Instruments & Apparatus (3841)	272053069

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1366268	Faiz Jon Kayyem	5964 La Place Court Carlsbad CA 92008	Svp, Research & Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-01-15	10,519	$14.00	608,789	No	4	S	Indirect	IFIN LP
Common Stock	Disposition	2014-01-16	39,481	$14.06	569,308	No	4	S	Indirect	IFIN LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	IFIN LP
No	4	S	Indirect	IFIN LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	61,651	Indirect	HI Charitable Remainder Uni Trust
Common Stock	106,155	Direct
Common Stock	100,934	Indirect	The Jon Faiz Kayyem and Paige N. Gates Family Trust, dated April 1, 2000

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by IFIN LP in August 2013. Under the terms of this 10b5-1 trading plan, up to an aggregate of 300,000 shares of the Issuer's common stock are scheduled to occur between January 1, 2014 and December 31, 2015, provided that designated minimum share prices are met. As of the date of this report and following the transactions reported herein, a total of 150,000 shares have been sold under the 10b5-1 plan. IFIN LP adopted this 10b5-1 trading plan as required by its investment policy guidelines, which limit the aggregate value of its investments in any single stock.
Dr. Kayyem is the trustee of the HI Charitable Remainder Uni Trust, trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust, dated April 1, 2000 and the President of In-Motion LLC, the general partner of IFIN LP. Dr. Kayyem disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
This transaction was executed in multiple trades at prices ranging from $14.00 to $14.17. The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the reported transactions were effected.